Aspirin benefit for cancer survival

Aspirin can double the life expectancy of patients with cancers affecting the gastrointestinal tract, a major study has found.

Men and women with a range of cancers who took the anti-inflammatory pain killer experienced a “significant” survival benefit compared with those who did not.

Researchers analysed data from nearly 14,000 patients in the Netherlands, around half of whom were in the habit of taking aspirin.